{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:44:13Z","timestamp":1793321053068,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":388,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.cell.2021.05.001","type":"journal-article","created":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T11:10:29Z","timestamp":1622545829000},"page":"3486-3501.e21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever"],"prefix":"10.1016","volume":"184","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1455-9318","authenticated-orcid":false,"given":"J. Maximilian","family":"Fels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2074-5416","authenticated-orcid":false,"given":"Daniel P.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel S.","family":"Wirchnianski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Vergnolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafna M.","family":"Abelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal L.","family":"Moyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akaash K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0221-354X","authenticated-orcid":false,"given":"Jennifer T.","family":"Aguilan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana I.","family":"Kuehne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0853-2429","authenticated-orcid":false,"given":"Noel T.","family":"Pauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell R.","family":"Bakken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth K.","family":"Nyakatura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hellert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Lobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Balinandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius J.","family":"Lutwama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6857-1024","authenticated-orcid":false,"given":"Larry","family":"Zeitlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9953-7988","authenticated-orcid":false,"given":"Felix A.","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Sidoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7557-9219","authenticated-orcid":false,"given":"Zachary A.","family":"Bornholdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Dye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0232-7077","authenticated-orcid":false,"given":"Kartik","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2021.05.001_bib1","doi-asserted-by":"crossref","first-page":"e0007100","DOI":"10.1371\/journal.pntd.0007100","article-title":"Clinical and molecular epidemiology of Crimean-Congo hemorrhagic fever in Oman","volume":"13","author":"Al-Abri","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cell.2021.05.001_bib2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.immuni.2019.06.024","article-title":"Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B cell Responses to Influenza Hemagglutinin","volume":"51","author":"Andrews","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2021.05.001_bib3","doi-asserted-by":"crossref","first-page":"e1002930","DOI":"10.1371\/journal.ppat.1002930","article-title":"Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope","volume":"8","author":"Austin","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cell.2021.05.001_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2010.08.007","article-title":"The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity","volume":"8","author":"Beltramello","year":"2010","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cell.2021.05.001_bib5","doi-asserted-by":"crossref","first-page":"11089","DOI":"10.1128\/JVI.01383-10","article-title":"Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model","volume":"84","author":"Bente","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2021.05.001_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.antiviral.2013.07.006","article-title":"Crimean-Congo hemorrhagic fever: history, epidemiology, pathogenesis, clinical syndrome and genetic diversity","volume":"100","author":"Bente","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.cell.2021.05.001_bib7","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1099\/vir.0.019034-0","article-title":"Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice","volume":"91","author":"Bereczky","year":"2010","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.cell.2021.05.001_bib8","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1128\/JVI.79.10.6152-6161.2005","article-title":"Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins","volume":"79","author":"Bertolotti-Ciarlet","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2021.05.001_bib9","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1073\/pnas.1701410114","article-title":"Emerging infectious diseases: A proactive approach","volume":"114","author":"Bloom","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2021.05.001_bib10","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.aad5788","article-title":"Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak","volume":"351","author":"Bornholdt","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.05.001_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.chom.2018.12.005","article-title":"A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates","volume":"25","author":"Bornholdt","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cell.2021.05.001_bib12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1743-422X-9-122","article-title":"Expression of interferon-induced antiviral genes is delayed in a STAT1 knockout mouse model of Crimean-Congo hemorrhagic fever","volume":"9","author":"Bowick","year":"2012","journal-title":"Virol. J."},{"key":"10.1016\/j.cell.2021.05.001_bib13","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.ympev.2010.01.006","article-title":"Ancient common ancestry of Crimean-Congo hemorrhagic fever virus","volume":"55","author":"Carroll","year":"2010","journal-title":"Mol. Phylogenet. Evol."},{"key":"10.1016\/j.cell.2021.05.001_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature14411","article-title":"Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117","volume":"522","author":"Caskey","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.05.001_bib15","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1038\/emboj.2009.245","article-title":"Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody","volume":"28","author":"Cherrier","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2021.05.001_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cell.2021.05.001_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzyme Regul."},{"key":"10.1016\/j.cell.2021.05.001_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3201\/eid2101.141413","article-title":"Health care response to CCHF in US soldier and nosocomial transmission to health care providers, Germany, 2009","volume":"21","author":"Conger","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.cell.2021.05.001_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature12966","article-title":"Proof of principle for epitope-focused vaccine design","volume":"507","author":"Correia","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.05.001_bib20","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.1073\/pnas.1510199112","article-title":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus","volume":"112","author":"Corti","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2021.05.001_bib21","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1099\/vir.0.82640-0","article-title":"A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particles","volume":"88","author":"Crill","year":"2007","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.cell.2021.05.001_bib22","doi-asserted-by":"crossref","first-page":"e0008637","DOI":"10.1371\/journal.pntd.0008637","article-title":"Crimean-Congo hemorrhagic fever virus strains Hoti and Afghanistan cause viremia and mild clinical disease in cynomolgus monkeys","volume":"14","author":"Cross","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cell.2021.05.001_bib23","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2019.04.036","article-title":"Longitudinal analysis of the human B cell response to ebola virus infection","volume":"177","author":"Davis","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.05.001_bib24","doi-asserted-by":"crossref","first-page":"407","DOI":"10.15252\/emmm.201505986","article-title":"Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis","volume":"8","author":"De Benedictis","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cell.2021.05.001_bib25","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.05.001_bib26","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.3390\/toxins7061854","article-title":"Monoclonal Antibody Combinations that Present Synergistic Neutralizing Activity: A Platform for Next-Generation Anti-Toxin Drugs","volume":"7","author":"Diamant","year":"2015","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.cell.2021.05.001_bib27","doi-asserted-by":"crossref","first-page":"e01559","DOI":"10.1128\/mBio.01559-15","article-title":"Genotypic differences in dengue virus neutralization are explained by a single amino acid mutation that modulates virus breathing","volume":"6","author":"Dowd","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.cell.2021.05.001_bib28","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature11741","article-title":"Functional and evolutionary insight from the crystal structure of rubella virus protein E1","volume":"493","author":"DuBois","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.05.001_bib29","doi-asserted-by":"crossref","first-page":"e00028-20","DOI":"10.1128\/mBio.00028-20","article-title":"Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model","volume":"11","author":"Duehr","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.cell.2021.05.001_bib30","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1469-0691.2006.01445.x","article-title":"Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited","volume":"12","author":"Ergonul","year":"2006","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.cell.2021.05.001_bib31","first-page":"107","article-title":"Yeast transformation by the LiAc\/SS Carrier DNA\/PEG method","volume":"313","author":"Gietz","year":"2006","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.cell.2021.05.001_bib32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.immuni.2020.01.001","article-title":"Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization","volume":"52","author":"Gilchuk","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2021.05.001_bib33","doi-asserted-by":"crossref","first-page":"eaaj1879","DOI":"10.1126\/sciimmunol.aaj1879","article-title":"Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors","volume":"1","author":"Gilman","year":"2016","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cell.2021.05.001_bib34","doi-asserted-by":"crossref","first-page":"eaaw9535","DOI":"10.1126\/sciadv.aaw9535","article-title":"GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection","volume":"5","author":"Golden","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cell.2021.05.001_bib35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.immuni.2018.01.005","article-title":"Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation","volume":"48","author":"Goodwin","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2021.05.001_bib36","doi-asserted-by":"crossref","first-page":"e1005813","DOI":"10.1371\/journal.ppat.1005813","article-title":"Mechanistic Insight into Bunyavirus-Induced Membrane Fusion from Structure-Function Analyses of the Hantavirus Envelope Glycoprotein Gc","volume":"12","author":"Guardado-Calvo","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cell.2021.05.001_bib37","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41564-018-0141-7","article-title":"A cynomolgus macaque model for Crimean-Congo haemorrhagic fever","volume":"3","author":"Haddock","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.cell.2021.05.001_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/v12030259","article-title":"Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein","volume":"12","author":"Hao","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.cell.2021.05.001_bib39","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/s41467-019-08832-8","article-title":"Orthobunyavirus spike architecture and recognition by neutralizing antibodies","volume":"10","author":"Hellert","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2021.05.001_bib40","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/jmedent\/15.4.307","article-title":"The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa","volume":"15","author":"Hoogstraal","year":"1979","journal-title":"J.\u00a0Med. Entomol."},{"key":"10.1016\/j.cell.2021.05.001_bib41","doi-asserted-by":"crossref","first-page":"358","DOI":"10.4161\/mabs.23977","article-title":"Structure reveals function of the dual variable domain immunoglobulin (DVD-Ig\u2122) molecule","volume":"5","author":"Jakob","year":"2013","journal-title":"MAbs"},{"key":"10.1016\/j.cell.2021.05.001_bib42","first-page":"CD012713","article-title":"Ribavirin for treating Crimean Congo haemorrhagic fever","volume":"6","author":"Johnson","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.cell.2021.05.001_bib43","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.celrep.2018.10.031","article-title":"A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human Primates","volume":"25","author":"Keeffe","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2021.05.001_bib44","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature11604","article-title":"HIV therapy by a combination of broadly neutralizing antibodies in humanized mice","volume":"492","author":"Klein","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.05.001_bib45","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1089\/vbz.2015.1855","article-title":"Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice","volume":"15","author":"Kortekaas","year":"2015","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.cell.2021.05.001_bib46","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.05.001_bib47","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-8674(01)00303-8","article-title":"The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH","volume":"105","author":"Lescar","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.05.001_bib48","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1128\/JVI.72.4.3235-3240.1998","article-title":"Synergistic neutralization of simian-human immunodeficiency virus SHIV-vpu+ by triple and quadruple combinations of human monoclonal antibodies and high-titer anti-human immunodeficiency virus type 1 immunoglobulins","volume":"72","author":"Li","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2021.05.001_bib49","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nsmb.1382","article-title":"Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins","volume":"15","author":"Lok","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cell.2021.05.001_bib50","doi-asserted-by":"crossref","first-page":"e0166744","DOI":"10.1371\/journal.pone.0166744","article-title":"Phylogeography of crimean congo hemorrhagic fever virus","volume":"11","author":"Lukashev","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cell.2021.05.001_bib51","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jmb.2012.11.010","article-title":"Rapid conformational epitope mapping of anti-gp120 antibodies with a designed mutant panel displayed on yeast","volume":"425","author":"Mata-Fink","year":"2013","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.cell.2021.05.001_bib52","doi-asserted-by":"crossref","first-page":"e171427","DOI":"10.3201\/eid2409.171427","article-title":"World health organization methodology to prioritize emerging infectious diseases in need of research and development","volume":"24","author":"Mehand","year":"2018","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.cell.2021.05.001_bib53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/trstmh\/trv050","article-title":"The global distribution of Crimean-Congo hemorrhagic fever","volume":"109","author":"Messina","year":"2015","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.cell.2021.05.001_bib54","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nm.4396","article-title":"Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever","volume":"23","author":"Mire","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2021.05.001_bib55","doi-asserted-by":"crossref","first-page":"e02005-19","DOI":"10.1128\/JVI.02005-19","article-title":"Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38","volume":"94","author":"Mishra","year":"2020","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.cell.2021.05.001_bib56","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A randomized, controlled trial of ebola virus disease therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cell.2021.05.001_bib57","doi-asserted-by":"crossref","first-page":"e1008061","DOI":"10.1371\/journal.ppat.1008061","article-title":"Human monoclonal antibodies against chikungunya virus target multiple distinct epitopes in the E1 and E2 glycoproteins","volume":"15","author":"Quiroz","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cell.2021.05.001_bib58","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20151960","article-title":"Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design","volume":"213","author":"Rappuoli","year":"2016","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.cell.2021.05.001_bib59","article-title":"Molecular rationale for hantavirus neutralization by a reservoir host-derived monoclonal antibody","author":"Rissanen","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.cell.2021.05.001_bib60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1126\/sciimmunol.aan6809","article-title":"Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors","volume":"2","author":"Rogers","year":"2017","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cell.2021.05.001_bib61","doi-asserted-by":"crossref","first-page":"15411","DOI":"10.1038\/ncomms15411","article-title":"Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope","volume":"8","author":"Rouvinski","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2021.05.001_bib62","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2020.08.023","article-title":"The hantavirus surface glycoprotein lattice and its fusion control mechanism","volume":"183","author":"Serris","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2021.05.001_bib63","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1126\/science.aay5051","article-title":"De novo protein design enables the precise induction of RSV-neutralizing antibodies","volume":"368","author":"Sesterhenn","year":"2020","journal-title":"Science"},{"issue":"Suppl 4","key":"10.1016\/j.cell.2021.05.001_bib64","doi-asserted-by":"crossref","first-page":"S801","DOI":"10.1093\/clinids\/11.Supplement_4.S801","article-title":"Antibody response in Crimean-Congo hemorrhagic fever","volume":"11","author":"Shepherd","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.cell.2021.05.001_bib65","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1086\/421093","article-title":"Crimean-Congo hemorrhagic fever: prevention and control limitations in a resource-poor country","volume":"38","author":"Smego","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cell.2021.05.001_bib66","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.antiviral.2017.11.019","article-title":"Second International Conference on Crimean-Congo Hemorrhagic Fever","volume":"150","author":"Spengler","year":"2018","journal-title":"Antiviral Res."},{"key":"10.1016\/j.cell.2021.05.001_bib67","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.coviro.2018.12.002","article-title":"Crimean-Congo hemorrhagic fever and expansion from endemic regions","volume":"34","author":"Spengler","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.cell.2021.05.001_bib68","doi-asserted-by":"crossref","first-page":"eaax4380","DOI":"10.1126\/science.aax4380","article-title":"A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses","volume":"366","author":"Steichen","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.05.001_bib69","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.05.001_bib70","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1371\/journal.pmed.0030237","article-title":"Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants","volume":"3","author":"ter Meulen","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.cell.2021.05.001_bib71","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group","volume":"102","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/j.cell.2021.05.001_bib72","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.cell.2021.05.001_bib73","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"Voss","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.cell.2021.05.001_bib74","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41564-019-0411-z","article-title":"Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus","volume":"4","author":"Wang","year":"2019","journal-title":"Nat. Microbiol."},{"issue":"W1","key":"10.1016\/j.cell.2021.05.001_bib75","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cell.2021.05.001_bib76","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0042-6822(80)90372-4","article-title":"Determination of the number of nonoverlapping antigenic areas on Hong Kong (H3N2) influenza virus hemagglutinin with monoclonal antibodies and the selection of variants with potential epidemiological significance","volume":"104","author":"Webster","year":"1980","journal-title":"Virology"},{"key":"10.1016\/j.cell.2021.05.001_bib77","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1126\/science.aag3267","article-title":"A \u201cTrojan horse\u201d bispecific-antibody strategy for broad protection against ebolaviruses","volume":"354","author":"Wec","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.05.001_bib78","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.chom.2018.12.004","article-title":"Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection","volume":"25","author":"Wec","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cell.2021.05.001_bib79","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1073\/pnas.1921388117","article-title":"Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine","volume":"117","author":"Wec","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2021.05.001_bib80","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1126\/science.abc7424","article-title":"Broad neutralization of SARS-related viruses by human monoclonal antibodies","volume":"369","author":"Wec","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2021.05.001_bib81","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nbt1345","article-title":"Simultaneous targeting of multiple disease mediators by a dual-variable-domain immunoglobulin","volume":"25","author":"Wu","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cell.2021.05.001_bib82","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/protein\/gzt047","article-title":"Addressing polyspecificity of antibodies selected from an in\u00a0vitro yeast presentation system: a FACS-based, high-throughput selection and analytical tool","volume":"26","author":"Xu","year":"2013","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.cell.2021.05.001_bib83","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1073\/pnas.1304300110","article-title":"Dengue structure differs at the temperatures of its human and mosquito hosts","volume":"110","author":"Zhang","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2021.05.001_bib84","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1093\/infdis\/jit061","article-title":"Lethal Crimean-Congo hemorrhagic fever virus infection in interferon \u03b1\/\u03b2 receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy","volume":"207","author":"Zivcec","year":"2013","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.cell.2021.05.001_bib85","doi-asserted-by":"crossref","first-page":"e0004259","DOI":"10.1371\/journal.pntd.0004259","article-title":"Assessment of Inhibitors of Pathogenic Crimean-Congo Hemorrhagic Fever Virus Strains Using Virus-Like Particles","volume":"9","author":"Zivcec","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.cell.2021.05.001_bib86","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/v8040106","article-title":"Molecular Insights into Crimean-Congo Hemorrhagic Fever Virus","volume":"8","author":"Zivcec","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.cell.2021.05.001_bib87","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.antiviral.2017.08.014","article-title":"Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus","volume":"146","author":"Zivcec","year":"2017","journal-title":"Antiviral Res."},{"key":"10.1016\/j.cell.2021.05.001_bib88","doi-asserted-by":"crossref","first-page":"12198","DOI":"10.1128\/JVI.75.24.12198-12208.2001","article-title":"Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodies","volume":"75","author":"Zwick","year":"2001","journal-title":"J.\u00a0Virol."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867421005845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867421005845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T11:54:15Z","timestamp":1758801255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867421005845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":88,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0092867421005845"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2021.05.001","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2021.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}